Computational approaches for the study of the role of small molecules in diseases

Anighoro, 2014, Polypharmacology: challenges and opportunities in drug discovery, J. Med. Chem., 19, 7874, 10.1021/jm5006463 Campillos, 2008, Drug target identification using side-effect similarity, Science, 5886, 263, 10.1126/science.1158140 Emanuel, 2015, The solution to drug prices, New York Times Firth, 2009, DECIPHER: database of chromosomal imbalance and phenotype in humans using ensembl resources, Am. J. Hum. Genet., 4, 524, 10.1016/j.ajhg.2009.03.010 Garnett, 2012, Systematic identification of genomic markers of drug sensitivity in cancer cells, Nature, 7391, 570, 10.1038/nature11005 Gaulton, 2011, ChEMBL: a large-scale bioactivity database for drug discovery, Nucleic Acids Res., D1100 Guney, 2016, Network-based in silico drug efficacy screening, Nat. Commun., 10331 Gunther, 2008, SuperTarget and Matador: resources for exploring drug-target relationships, Nucleic Acids Res., D919 Hopkins, 2002, The druggable genome, Nat. Rev. Drug Discov., 9, 727, 10.1038/nrd892 Imming, 2006, Drugs, their targets and the nature and number of drug targets, Nat. Rev. Drug Discov., 10, 821, 10.1038/nrd2132 Jalencas, 2013, On the origins of drug polypharmacology, MedChemComm, 1, 80, 10.1039/C2MD20242E Keiser, 2007, Relating protein pharmacology by ligand chemistry, Nat. Biotechnol., 2, 197, 10.1038/nbt1284 Kohler, 2014, The Human Phenotype Ontology project: linking molecular biology and disease through phenotype data, Nucleic Acids Res., D966, 10.1093/nar/gkt1026 Kuhn, 2010, A side effect resource to capture phenotypic effects of drugs, Mol. Syst. Biol., 343, 10.1038/msb.2009.98 Kuhn, 2016, The SIDER database of drugs and side effects, Nucleic Acids Res., D1, D1075, 10.1093/nar/gkv1075 Laird, 2004, Structure-based generation of viable leads from small combinatorial libraries, Curr. Opin. Drug Discov. Dev., 3, 354 Lamb, 2006, The Connectivity Map: using gene-expression signatures to connect small molecules, genes, and disease, Science, 5795, 1929, 10.1126/science.1132939 Li, 2015, Identification of drug-target interaction from interactome network with ‘guilt-by-association’ principle and topology features, Bioinformatics, 32, 1057, 10.1093/bioinformatics/btv695 Liu, 2014, Unveiling new biological relationships using shared hits of chemical screening assay pairs, Bioinformatics, 17, i579, 10.1093/bioinformatics/btu468 Liu, 2013, HitPick: a web server for hit identification and target prediction of chemical screenings, Bioinformatics, 15, 1910, 10.1093/bioinformatics/btt303 Mestres, 2008, Data completeness – the Achilles heel of drug-target networks, Nat. Biotechnol., 9, 983, 10.1038/nbt0908-983 Paolini, 2006, Global mapping of pharmacological space, Nat. Biotechnol., 7, 805, 10.1038/nbt1228 Peters, 2013, Polypharmacology – foe or friend?, J. Med. Chem., 22, 8955, 10.1021/jm400856t Petrone, 2012, Rethinking molecular similarity: comparing compounds on the basis of biological activity, ACS Chem. Biol., 8, 1399, 10.1021/cb3001028 Pinero, 2015, DisGeNET: a discovery platform for the dynamical exploration of human diseases and their genes, Database (Oxford), bav028, 10.1093/database/bav028 Rees, 2016, Correlating chemical sensitivity and basal gene expression reveals mechanism of action, Nat. Chem. Biol., 2, 109, 10.1038/nchembio.1986 Seiler, 2008, ChemBank: a small-molecule screening and cheminformatics resource database, Nucleic Acids Res., D351 Shoemaker, 2006, The NCI60 human tumour cell line anticancer drug screen, Nat. Rev. Cancer, 10, 813, 10.1038/nrc1951 Vogt, 2014, Molecularly and clinically related drugs and diseases are enriched in phenotypically similar drug-disease pairs, Genome Med., 52 Vogt, 2014, Systematic analysis of gene properties influencing organ system phenotypes in mammalian perturbations, Bioinformatics, 21, 3093, 10.1093/bioinformatics/btu487 Wang, 2009, PubChem: a public information system for analyzing bioactivities of small molecules, Nucleic Acids Res., W623, 10.1093/nar/gkp456 Waring, 2015, An analysis of the attrition of drug candidates from four major pharmaceutical companies, Nat. Rev. Drug Discov., 7, 475, 10.1038/nrd4609 Wassermann, 2015, The opportunities of mining historical and collective data in drug discovery, Drug Discov. Today, 4, 422, 10.1016/j.drudis.2014.11.004 Welter, 2014, The NHGRI GWAS Catalog, a curated resource of SNP-trait associations, Nucleic Acids Res., D1001, 10.1093/nar/gkt1229 Wishart, 2006, DrugBank: a comprehensive resource for in silico drug discovery and exploration, Nucleic Acids Res., D668, 10.1093/nar/gkj067 Xia, 2004, Classification of kinase inhibitors using a Bayesian model, J. Med. Chem., 18, 4463, 10.1021/jm0303195 Yildirim, 2007, Drug-target network, Nat. Biotechnol., 10, 1119, 10.1038/nbt1338